GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹5,630 Cr | ₹5,881 Cr | ₹6,840 Cr | ₹7,115 Cr | ₹6,709 Cr |
What is the latest Total Non-Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹5,630 Cr |
| Mar2024 | ₹5,881 Cr |
| Mar2023 | ₹6,840 Cr |
| Mar2022 | ₹7,115 Cr |
| Mar2021 | ₹6,709 Cr |
How is Total Non-Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,630 Cr | -4.27 | |
| Mar2024 | ₹5,881 Cr | -14.03 | |
| Mar2023 | ₹6,840 Cr | -3.86 | |
| Mar2022 | ₹7,115 Cr | 6.04 | |
| Mar2021 | ₹6,709 Cr | - | |
Compare Total Non-Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹59,925.2 Cr | 3% | 9.5% | 61.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 3% |
9.5% |
61.3% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses